Ignite Creation Date:
2024-05-06 @ 7:51 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06157892
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-11-27
Brief Title:
A Study of Disitamab Vedotin Alone or With Other Anticancer Drugs in Solid Tumors
Sponsor:
Seagen Inc
Organization:
Seagen Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Triple Negative Breast Neoplasms |
| Breast Neoplasms |
| Gastroesophageal Junction Adenocarcinoma |
| HER2 Low Breast Neoplasms |
| HER2 Positive Breast Neoplasms |
| Stomach Neoplasms |